• Other
  • Current

Blade Therapeutics is a discovery stage drug development company. Our mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Our leadership team has extensive experience at developing drugs that treat fibrotic disorders. We are also partnering with international experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.